No abstract available.
Laparoscopy* ; Ureter*

No abstract available.
Urodynamics*

PURPOSE: It is important to know for transurethral resection of prostate (TURP) affecting the serum prostate specific antigen (PSA) value how long one should wait before being able to ~ obtain an accurate and meaningful serum PSA level. We evaluated the change of serum PSA concentration in patients with benign prostate hypertrophy(BPH) before and after TURP in association with time course and resected prostatic weight. MATERIALS AND METHOD: The effect of TURP was examined in 27 patients with BPH (mean age: 64 years; range: 55-79 years). The serum PSA levels were measured serially (before and 1, 3, 5, 7, 14, 30, 60, 90 days after TURP) by Abott IMX assay. RESULTS: The level of serum PSA appeared to be consistent with prostatic volume by transrectal ultrasonography(TRUS) and was elevated by about 0.16 ng/mL for each gram of hyperplastic tissue present (p=0.375, p=0.058). TURP caused an immediate elevation in the serum PSA concentration, with a median increase of 19 ng/mL (p=0.0001). The larger resected group showed a dramatic and statistically significant PSA rise immediately after TURP than the smaller resected group (p=0.023). From the 15 post-operative day, the PSA concentrations continued slightly lower than that of pre-operative day (p=0.0001), and was still decreased on 30 days (p=0.0001). The median time to return to a baseline level of PSA was 30 days (range: 1460 days) after TURP. CONCLUSION: These findings indicate that TURP caused an immediate increase in the serum PSA level, which generally return to stable, baseline level within 30 days. However, because in some patients the serum PSA still remained elevated than upper normal limit after 30 days, it is recommended that a serum PSA determination should be obtained for at least 60 days after TURP.
Humans ; Hypertrophy* ; Prostate* ; Prostate-Specific Antigen* ; Transurethral Resection of Prostate*

PURPOSE: It is important to know for transurethral resection of prostate (TURP) affecting the serum prostate specific antigen (PSA) value how long one should wait before being able to ~ obtain an accurate and meaningful serum PSA level. We evaluated the change of serum PSA concentration in patients with benign prostate hypertrophy(BPH) before and after TURP in association with time course and resected prostatic weight. MATERIALS AND METHOD: The effect of TURP was examined in 27 patients with BPH (mean age: 64 years; range: 55-79 years). The serum PSA levels were measured serially (before and 1, 3, 5, 7, 14, 30, 60, 90 days after TURP) by Abott IMX assay. RESULTS: The level of serum PSA appeared to be consistent with prostatic volume by transrectal ultrasonography(TRUS) and was elevated by about 0.16 ng/mL for each gram of hyperplastic tissue present (p=0.375, p=0.058). TURP caused an immediate elevation in the serum PSA concentration, with a median increase of 19 ng/mL (p=0.0001). The larger resected group showed a dramatic and statistically significant PSA rise immediately after TURP than the smaller resected group (p=0.023). From the 15 post-operative day, the PSA concentrations continued slightly lower than that of pre-operative day (p=0.0001), and was still decreased on 30 days (p=0.0001). The median time to return to a baseline level of PSA was 30 days (range: 1460 days) after TURP. CONCLUSION: These findings indicate that TURP caused an immediate increase in the serum PSA level, which generally return to stable, baseline level within 30 days. However, because in some patients the serum PSA still remained elevated than upper normal limit after 30 days, it is recommended that a serum PSA determination should be obtained for at least 60 days after TURP.
Humans ; Hypertrophy* ; Prostate* ; Prostate-Specific Antigen* ; Transurethral Resection of Prostate*

Retrocaval ureter is a congenital venous anomaly, in which the ureter passes behind and is compassed by inferior vena cava. We experienced a case of multiple urothelial cell carcinoma in retrocaval ureter in 68 years old male. He was treated with transurethral resection of bladder tumor and right nephroureterectomy with bladder cuff excision.
Aged ; Carcinoma, Transitional Cell ; Humans ; Male ; Retrocaval Ureter* ; Ureter ; Urinary Bladder ; Urinary Bladder Neoplasms ; Vena Cava, Inferior

No abstract available.
Chin* ; Humans ; Membranes* ; Prostate* ; Prostatic Neoplasms* ; RNA, Messenger* ; RNA-Directed DNA Polymerase*

Bladder injury is a rare complication of inguinal herniorrhaphy. Infants less than 6 months old may be more at risk because the medial aspect of indirect inguinal hernia sacs are associated closely with the wall of bladder (bladder ear). We report a case of injured bladde. ear during inguinal herniorrhaphy.
Ear* ; Hernia, Inguinal ; Herniorrhaphy ; Humans ; Infant ; Urinary Bladder*

Hemangiomas of the bladder are a rare but recognized cause of gross hematuria. In many cases, the tumor shows the characteristics of an iceberg, with considerable extravesical extension making endoscopic management less suitable. In spite of its benign nature, bladder hemangioma may grow continuously, and spontaneous regression is rare. They need to be adequately treated to avoid recurrent fatal hematuria and appropriately followed up to detect recurrency or persistency. We report a case of cavernous hemangioma of the bladder in 26-year-old woman, who presented recurrent gross hematuria and was treated with partial cystectomy.
Adult ; Cystectomy ; Female ; Hemangioma ; Hemangioma, Cavernous* ; Hematuria ; Humans ; Ice Cover ; Urinary Bladder*

Among developmental abnormalities of the upper urinary tracts, duplication of the upper urinary tract is a relatively common finding, while triplication of the pelvis and ureter is a rare finding. Furthermore, quadruplication of the upper urinary tract is exceedingly unusual. We present a case of unilateral incomplete quadruplicated ureter that was associated with ipsilateral ectopic ureteral orifice and renal dysplasia.
Pelvis ; Ureter* ; Urinary Tract

PURPOSE: The therapeutic approach to patients with emphysematous pyelonephritis long has been a debatable issue. So we evaluated the efficacy of percutaneous drainage in patients with emphysematous pyelonephritis. MATERIALS AND METHODS: 7 patients with emphysematous pyelonephritis underwent percutaneous drainage. The result was classified as cure, partial success, recurrence, or failure. The mean drainage period and complication were analyzed. RESULTS: There were 2 men and 5 women with 49 to 72 years old(mean age 60) suffering from diabets mellitus. Six patients(87.5%) were cured with percutaneous drainage and antibiotics, but one patient who had diffuse renal parenchymal destruction without perirenal fluid collection was failed. The mean catheterization Period was 26.3 days(range 10 to 45). Bacteremia after percutaneous drainage in one patient was cured with antibiotic therapy. CONCLUSIONS: Percutaneous drainage can be a lifesaving alternative method in critically ill, high risk patient with emphysematous pyelonephritis.
Anti-Bacterial Agents ; Bacteremia ; Catheterization ; Catheters ; Critical Illness ; Drainage* ; Female ; Humans ; Male ; Pyelonephritis* ; Recurrence